Status:
COMPLETED
ANGIOLITE PMCF Study ( rEPIC04F )
Lead Sponsor:
Fundación EPIC
Conditions:
Coronary Artery Disease (CAD)
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Angiolite sirolimus eluting stent to meet EU Medical...
Detailed Description
The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the Angiolite Sirolimus Elu...
Eligibility Criteria
Inclusion
- Patients treated with ANGIOLITE according to routine hospital practice and following instructions for use
- Informed consent signed
Exclusion
- • Not meet inclusion criteria
Key Trial Info
Start Date :
September 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 3 2024
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT05292014
Start Date
September 26 2022
End Date
August 3 2024
Last Update
June 15 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic de Barcelona
Barcelona, Spain, 08036
2
H. Puerta Del Mar
Cadiz, Spain, 11009
3
Hospital Universitario de Leon
León, Spain, 24080
4
Hospital Universitario Virgen de La Victoria
Málaga, Spain, 29010